2-bromopalmitate has been researched along with isoproterenol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Faccini, JM; Greaves, P; Higgins, AJ | 1 |
| Chai, SP; Fong, JC; Leu, SJ | 1 |
| Chen, M; Harmon, CM; Loux, TJ; Yang, Y | 1 |
3 other study(ies) available for 2-bromopalmitate and isoproterenol
| Article | Year |
|---|---|
Coronary hyperemia and cardiac hypertrophy following inhibition of fatty acid oxidation. Evidence of a regulatory role for cytosolic phosphorylation potential.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Cardiomegaly; Coronary Circulation; Creatine; Cytosol; Dogs; Fatty Acids; Glycine; Hemodynamics; Isoproterenol; Organ Size; Oxidation-Reduction; Oxygen Consumption; Palmitates; Phosphocreatine; Phosphorylation | 1985 |
Differential inhibition of lipolysis by 2-bromopalmitic acid and 4-bromocrotonic acid in 3T3-L1 adipocytes.
Topics: 3T3 Cells; Adipocytes; Animals; Bucladesine; Crotonates; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fatty Acids; Isoproterenol; Lipolysis; Mice; Palmitates; Sterol Esterase | 1997 |
Regulation of FAT/CD36 mRNA gene expression by long chain fatty acids in the differentiated 3T3-L1 cells.
Topics: 3T3-L1 Cells; Adipocytes; Analysis of Variance; Animals; Blotting, Northern; Blotting, Western; CD36 Antigens; Cell Line; Cells, Cultured; Dose-Response Relationship, Drug; Fatty Acids; Gene Expression Regulation; Insulin; Isoproterenol; Kinetics; Mice; Palmitates; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stearic Acids | 2007 |